COMPETITIVE-INHIBITION OF HUMAN PLACENTAL AROMATASE BY N-N-OCTANOYLNORNICOTINE AND OTHER NORNICOTINE DERIVATIVES

被引:8
|
作者
BULLION, K
OHNISHI, S
OSAWA, Y
机构
[1] Endocrine Biochemistry, Department Medical Foundation of Buffalo Research Institute, Buffalo, NY, 14203
关键词
D O I
10.3109/07435809109106817
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In a study of the effect of N-n-octanoylnornicotine and other acyl derivatives of nornicotine on the aromatization of androstenedione by human placental microsomal aromatase, we found that N-n-octanoylnornicotine, a component of cigarette smoke, exhibited competitive inhibition with an apparent Ki of 0.65-mu-M. This is comparable to that of aminoglutethimide, the clinically-used non-steroidal aromatase inhibitor. N-n-Decanoylnornicotine and N-(4-hydroxyundecanoyl)nornicotine exhibited apparent Ki values of 0.86-mu-M and 0.24-mu-M, respectively. This study suggests that cigarette smoke components may have a direct effect on estrogen biosynthesis and that these compounds may prove to be useful parent structures for development of active site probes for further elucidation of estrogen biosynthesis and might eventually lead to the development of alternative non-steroidal anti-cancer therapy.
引用
收藏
页码:409 / 419
页数:11
相关论文
共 33 条
  • [31] GC-NICI-MS analysis of acetazolamide and other sulfonamide (R-SO2-NH2) drugs as pentafluorobenzyl derivatives [R-SO2-N(PFB)2] and quantification of pharmacological acetazolamide in human urine
    Begou, Olga
    Drabert, Kathrin
    Theodoridis, Georgios
    Tsikas, Dimitrios
    JOURNAL OF PHARMACEUTICAL ANALYSIS, 2020, 10 (01) : 49 - 59
  • [32] GC-NICI-MS analysis of acetazolamide and other sulfonamide (R-SO2-NH2) drugs as pentafluorobenzyl derivatives [R-SO2-N(PFB)2] and quantification of pharmacological acetazolamide in human urine
    Olga Begou
    Kathrin Drabert
    Georgios Theodoridis
    Dimitrios Tsikas
    Journal of Pharmaceutical Analysis, 2020, 10 (01) : 49 - 59
  • [33] The arylpiperazine derivatives N-(4-cyanophenylmethyl)4-( 2-diphenyl)-1-piperazinehexanamide and N-benzyl-4( 2-diphenyl)-1-piperazinehexanamide exert a long-lasting inhibition of human serotonin 5-HT7 receptor binding and cAMP signaling
    Atanes, Patricio
    Lacivita, Enza
    Rodriguez, Javier
    Brea, Jose
    Burgueno, Javier
    Miguel Vela, Jose
    Isabel Cadavid, Maria
    Isabel Loza, Maria
    Leopoldo, Marcello
    Castro, Marian
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2013, 1 (02):